Triphenylmethanamine

Triphenylmethanamine

SCHEMBL3607595

CCCCCC(=O)O.NC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 1/20 0.55
▸ GPR84 Q9NQS5 7/20 0.53
▸ PPARG P37231 7/20 0.53
▸ PPARD Q03181 7/20 0.53
▸ PPARA Q07869 7/20 0.53
▸ HDAC11 Q96DB2 5/20 0.53
▸ TSHR P16473 4/20 0.53
▸ PTPN1 P18031 3/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ TLR2 O60603 2/20 0.53
▸ TDP1 Q9NUW8 2/20 0.53
▸ FABP4 P15090 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ SLC22A6 Q4U2R8 1/20 0.53
▸ SLC22A8 Q8TCC7 1/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ ESR1 P03372 1/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ PDE4A P27815 1/20 0.53
▸ PDE3A Q14432 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Stearic Acid SCHEMBL29050833 0.87 GPR84 (0.55) AKR1B1GPR84PPARGPPARDPPARA
Stearic Acid SCHEMBL29050850 0.85 GPR84 (0.53) AKR1B1GPR84PPARGPPARDPPARA
Stearic Acid SCHEMBL7055196 0.83 SOAT1 (0.49) AKR1B1GPR84PPARGPPARDPPARA
Octanoic Acid SCHEMBL28930532 0.83 GPR84 (0.59) AKR1B1GPR84PPARGPPARDPPARA
Hexanoate SCHEMBL21145020 0.80 AKR1B1 (0.61) AKR1B1GPR84PPARGPPARDPPARA
Palmitic Acid SCHEMBL27612748 0.80 GPR84 (0.55) AKR1B1GPR84PPARGPPARDPPARA
Biphenyl SCHEMBL27337978 0.80 AKR1B1 (0.67) AKR1B1GPR84PPARGPPARDPPARA
Naphthalene SCHEMBL28148380 0.80 AKR1B1 (0.67) AKR1B1GPR84PPARGPPARDPPARA
Hexanoate SCHEMBL9303080 0.79 AKR1B1 (0.89) AKR1B1GPR84PPARGPPARDPPARA
Octanoic Acid SCHEMBL21145256 0.79 GPR84 (0.63) AKR1B1GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741044-B2 Libraries of oligomers labeled with different tags OXFORD GENE TECHNOLOGY IP LIMITED 2010-06-22 — — US disclosed
US-20090029866-A1 Libraries of oligomers labeled with different tags OXFORD GENE TECHNOLOGY IP LIMITED 2009-01-29 — — US disclosed
US-7399846-B2 Libraries of oligomers labeled with different tags OXFORD GENE TECHNOLOGY IP LIMITED (GB) 2008-07-15 — — US disclosed
US-20050003408-A1 Libraries of oligomers labeled with different tags ISIS INNOVATION LIMITED (GB) 2005-01-06 — — US disclosed
US-6780981-B1 MAKING A SET OF LABELLED COMPOUNDS BY THE USE OF PARTICULATE SUPPORT, COMPRISES DIVIDING THE SUPPORT INTO LOTS, PERFORMING A DIFFERENT CHEMICAL REACTION ON EACH LOT OF THE SUPPORT OXFORD GENE TECHNOLOGY IP LIMITED (GB) 2004-08-24 — — US disclosed
EP-1428810-A2 Libraries of oligomers labelled with different tags Oxford Gene Technology IP Limited (GB) 2004-06-16 — — EP disclosed
EP-1068216-B1 LIBRARIES OF OLIGOMERS LABELLED WITH DIFFERENT TAGS ISIS INNOVATION (GB) 2003-12-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029866-A1 Libraries of oligomers labeled with different tags FBL, HNRNPL, MTREX AKR1B1 4212/4885GPR84 4210/4885PPARG 4381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback